As a global medtech leader, Getinge is poised to enhance its influence on the Indian market through its India Innovation Centre (IIC) and by fostering collaborations with industry and academia, catering to an international market. The company has established a strong market presence in India across multiple product segments, such as ventilators (30%), heart-lung machines (50%), intra-aortic balloon pumps (70%), extracorporeal membrane oxygenation (ECMO) (90%), and operating room tables (25%).
Aruna Nayak, Managing Director of Getinge India Pvt. Ltd., elaborated on the company’s vital contributions to the growth of India’s healthcare sector, especially during the COVID-19 pandemic. Getinge facilitated life-saving support for healthcare professionals by supplying record numbers of advanced ventilators and ECMO products. Their service engineers also addressed approximately 10,000 service calls for these products.
Nayak added that India has emerged as one of Getinge’s top 10 global markets, with the company currently partnering with 10,000 Indian hospitals to construct a world-class infrastructure. Getinge is devoted to not only launching high-end technologies and devices in India, but also manufacturing them locally and exporting them to the US and European Union markets. The company is well-positioned to serve the Indian market with its premium products as healthcare infrastructure investments continue to rise.
In line with their Indian expansion plan, Getinge unveiled an Innovation Centre in Bangalore in January 2020. This facility concentrates on devising advanced and cost-effective solutions for emergency critical care and clinical trials. In addition, Getinge has collaborated with IIT Bombay’s School of Biomedical Engineering to create innovative and affordable emergency critical care solutions, drawing on insights from the pandemic.